HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?Zacks Investment Research • 09/24/25
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 09/19/25
Hologic's Strong International Traction to Continue Despite HeadwindsZacks Investment Research • 09/18/25
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?Zacks Investment Research • 09/15/25
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff HeadwindsZacks Investment Research • 09/10/25
Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Hologic's Panther Fusion Signals More Molecular Diagnostics UpsideZacks Investment Research • 09/04/25
Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare ConferenceBusiness Wire • 09/03/25
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?Zacks Investment Research • 08/29/25
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?Zacks Investment Research • 08/20/25
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health StrengthZacks Investment Research • 08/13/25
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?Zacks Investment Research • 08/08/25
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins DownZacks Investment Research • 07/31/25
Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 07/30/25